Most of the studied genes were rarely found to be mutated (<1% of cases), except for JAK2, where mutation V617F was found in 229 cases, contributing to 6% of all AML patients in this study (Supplementary Figure S1). Here, JAK2 is linked to acute myeloid leukemia.